PCOS Renamed PMOS to Better Reflect Women’s Experience

After more than a decade and a major global effort, polycystic ovary syndrome (PCOS) is getting a new name, and researchers hope the change will lead to a better understanding and care for women living with this condition.

What’s Changing?

PCOS will now be called polyendocrine metabolic ovarian syndrome (PMOS). The change comes after an evaluation process found that the old name didn’t fully reflect what many women were experiencing. Not everyone with the condition develops ovarian cysts, and the symptoms extended beyond the ovaries.

How Does PMOS Better Reflect the Condition?

According to international researchers involved in the efforts, PMOS affects about 170 million women worldwide. The new name is intended to better reflect the hormonal, metabolic, and reproductive effects connected to the condition. Experts believe this could improve diagnosis, treatment, and overall understanding during medical visits.

PMOS Symptoms

PMOS can present through symptoms like irregular periods, acne, excess facial or body hair, and high androgen levels. It can also appear through metabolic symptoms tied to insulin resistance, increasing the likelihood of weight gain, type 2 diabetes, and other long-term health issues. Researchers have also found links to higher levels of anxiety and depression, reinforcing that PMOS is not only a reproductive disorder.

There will be a transitional period as doctors and patients begin using the new name and the public becomes more educated on its meaning. Researchers hope the shift marks an important step toward more accurate diagnoses, personalized treatment, and better support for women living with the condition.